Posted by Maxime on April 12, 2005, at 14:17:33
In reply to Re: Everything is fine » Maxime, posted by ed_uk on April 12, 2005, at 12:15:10
Thanks Ed.
Actually my pdoc believes in T3 therapy. He did call my endo and asked that I be treated with Synthroid AND Cytomel. My endo said no.
My pdoc won't treat me with T3 because of Synthroid I am taking. He can't start prescribing Cytomel when I am already on Syntroid because then my Synthroid would have to be adjusted. And if my endo know that my pdoc is giving me T3 he will just say "bye-bye" which really wouldn't be that a big a deal in my opinion ... it would be welcomed. I already asked my PDOC to do this (to give me the T3)and he said no. That is why he initially wanted me to see the endo he send his patients to see. He must know that the endo will combine Synthroid and Cytomel.
It's so frustrating! But you already know I feel that way. :-)
Love,
Maxi
> Dear Maxime,
>
> I'm sorry that your endo is such a sh*t.
>
> Some pdocs use T3 to 'augment' antidepressants, even in patients who are not hypothyroid. Perhaps you could encourage your pdoc to prescribe it on this basis.
>
> PS. I'm not saying that you're not hypothyroid, I'm just trying to think of a way that you could get to try T3. You could say to your pdoc......
>
> Due to my symptoms, I believe that I'm hypo..... my endo says I'm not BUT.........
>
> It doesn't matter because you can prescribe T3 as an AD augmentor even if I'm not hypothyroid.
>
> It might work :-) Your pdoc could measure your thyroid function tests in order to monitor the T3 therapy. If your pdoc was to prescribe T3, he might want you to take a TCA.
>
> You could show this to your pdoc...............
>
> J Clin Psychiatry. 1992 Jan;53(1):16-8.
>
> Comment in:
> J Clin Psychiatry. 1993 Jul;54(7):277-9.
>
> T3 augmentation of antidepressant treatment in T4-replaced thyroid patients.
>
> Cooke RG, Joffe RT, Levitt AJ.
>
> Department of Psychiatry, University of Toronto, Ontario, Canada.
>
> BACKGROUND: Clinicians may not consider using the thyroid hormone liothyronine sodium (levorotary isomer of triiodothyronine [T3]) for augmentation of antidepressant drugs in depressed patients who are also receiving the precursor hormone levothyroxine (levorotary isomer of thyroxine [T4]) for thyroid disease. We now report on the successful use of T3 augmentation therapy in seven of nine depressed patients who were also receiving T4 for thyroid disease. METHOD: Following an earlier single case report, we prescribed T3 augmentation therapy for eight depressed patients who had not responded to an adequate antidepressant drug trial and who were receiving T4 therapy for thyroid disease. T3 was prescribed in open-label fashion, and response was judged by the clinician, whose assessment was supplemented by the use of standardized rating scales. RESULTS: Seven of the nine patients were judged to respond to T3 augmentation. CONCLUSION: These results are consistent with a report of differential effects for T3 versus T4 augmentation in depressed patients free of thyroid disease. The results have implications for the treatment of depression in the presence of thyroid disease and for the mechanism of thyroid hormone potentiation of antidepressants.
>
> Ed xxxxxxxxxxxxx
>
>
poster:Maxime
thread:482935
URL: http://www.dr-bob.org/babble/20050408/msgs/483372.html